Navigation Links
New FT-IR Spectrometer Series from Varian, Inc.
Date:3/31/2008

Unrivalled Performance Meets Simplicity for Routine and Research

Applications

PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 600-IR series of FT-IR (Fourier Transform Infrared) spectrometers, microscopes and imaging solutions. The series comprises a range of products for both routine analyses and advanced research applications.

FT-IR spectroscopy provides a simple, fast analytical tool to identify or characterize samples in a wide range of applications from QA/QC testing of raw materials in pharmaceutical laboratories to the detection of trace amounts of explosives or narcotics in forensic analysis.

FT-IR spectroscopy also has the ability to reveal the chemical fingerprint of a material, even in mixtures, allowing multiple materials to be identified simultaneously. Commonly used with a wide range of accessories such as ATR (Attenuated Total Reflectance), microscopes and imaging, FT-IR has pioneered new applications in areas such as biotechnology, food and agriculture and homeland security.

The Varian 600-IR series of spectrometers deliver the highest energy throughput, making them the ideal solution for research or method development applications. Designed for unrivalled performance, this new range of spectrometers and microscopes enables users to run samples faster, while maintaining the highest accuracy and reproducibility, saving both time and money.

Combining power with simplicity, the Varian 600-IR series intuitive, easy- to-use software and "plug and play" hardware simplify analyses and maximize output for both novice and expert users. The ability for users to upgrade their new instrumentation ensures that they can purchase a system that fits their budget today and will meet their needs in the future.

"The 600-IR Series offers unrivalled performance under real world conditions," said Martin O'Donoghue, Senior Vice Pr
'/>"/>

SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
2. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
3. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
4. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
5. U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
6. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
7. New nanotechnology television series does sweat the small stuff
8. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
9. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
10. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
11. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a ... Drug Administration (FDA) for the use of Medtronic,s ... (including a newly developed catheter) for use with ... intravenously to patients with pulmonary arterial hypertension.   ...
(Date:12/24/2014)... GMO corn cases filed across the ... in the process of being consolidated in a Kansas ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... District of Kansas. , Management of the Syngenta GMO ... U.S. District Judge John W. Lungstrum.* , As a ...
(Date:12/24/2014)... 23, 2014 The report ... as its definition, classification, application and industry ... manufacturing process, and product cost structure. Production ... The analysis also covers upstream raw materials, ... development trend and proposals. In the end, ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... All amounts are in US dollarsQUEBEC CITY, March ... AEZS ; TSX: AEZ), a global biopharmaceutical ... announced the signing of a development, commercialization and ... SNY ) for the development, registration and ...
... as buckyballs may be able to keep the nation,s ... prevent arteries from clogging up. , Engineers at Duke ... bacteria and other microorganisms to accumulate on the membranes ... leads the researchers to believe that coating pipes and ...
... OMAHA, Neb., March 5 Transgenomic, Inc. (OTC ... announced today its Molecular Laboratory has received notification ... offering its services in the state. Transgenomic ... including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology ...
Cached Biology Technology:AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 4AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 5Buckyballs could keep water systems flowing 2Buckyballs could keep water systems flowing 3Transgenomic Awarded Clinical Laboratory Certification in California 2Transgenomic Awarded Clinical Laboratory Certification in California 3
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and ... the addition of the "Biometrics Market in ... http://photos.prnewswire.com/prnh/20130307/600769 ... projects such as rural banking and upgradation of ... trends witnessed in the market. Besides the aforementioned ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... German . Aggressive male mating behavior might ... it can drive the species to extinction, an international research ... of Zurich has demonstrated in a mathematical model. ... of the individual is able to influence processes on a ...
... Most degenerative diseases begin with a gradual loss ... For example, in type I diabetes, hyperglycemia commonly develops when ... are lost; in Parkinson,s disease, motor dysfunction typically begins when ... by 70 to 80 percent. Finding ways to stop early ...
... Computer games are not just for kids. New research published ... Central open access journal, shows that computer games can speed ... stroke. It is often difficult for stroke victims to ... have problems six months later. Scientists in America looked at ...
Cached Biology News:Aggressive male mating behavior can endanger species 2New mouse model may lead to new therapies for degenerative diseases 2
Recombinant Mouse IL-23, CF...
... ActivePro In Vitro Translation ... E.coli lysate, synthesizes higher ... well as proteins with ... competing kits. This results ...
... , Customer Peptide Synthesis , Containing one Phospho-Amino ... mg will be returned to customer conjugation of peptide to KLH ... Maintenance 102 days/each , Pre-immune bleed ... , Test bleed (app. 5 ml) x1 ...
Donor Goat Serum...
Biology Products: